{"id":"sci-b-vac-hepatitis-b-vaccine","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site pain"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This vaccine contains inactivated hepatitis B virus particles that are used to stimulate the body's immune system to produce antibodies against the virus. The immune system then remembers how to fight the virus, providing long-term protection against infection.","oneSentence":"Sci-B-Vac Hepatitis B Vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis B virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:33:45.233Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of hepatitis B infection"}]},"trialDetails":[{"nctId":"NCT04531098","phase":"PHASE3","title":"A Bridging Study: Comparing Two Lots of Sci-B-Vac™ and Engerix-B in Healthy Adults","status":"COMPLETED","sponsor":"VBI Vaccines Inc.","startDate":"2006-03-02","conditions":"Hepatitis B","enrollment":402},{"nctId":"NCT04209400","phase":"PHASE3","title":"Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®","status":"COMPLETED","sponsor":"VBI Vaccines Inc.","startDate":"2014-04-18","conditions":"Hepatitis B","enrollment":100},{"nctId":"NCT04179786","phase":"PHASE4","title":"A Study to Qualify an In-house Reference Standard Batch of Sci-B-Vac™","status":"COMPLETED","sponsor":"VBI Vaccines Inc.","startDate":"2015-11-01","conditions":"Hepatitis B","enrollment":91},{"nctId":"NCT03408730","phase":"PHASE3","title":"Lot-to-lot Consistency of Sci-B-Vac™ in Adults","status":"COMPLETED","sponsor":"VBI Vaccines Inc.","startDate":"2017-12-14","conditions":"Hepatitis B Vaccines","enrollment":2838},{"nctId":"NCT03393754","phase":"PHASE3","title":"Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults","status":"COMPLETED","sponsor":"VBI Vaccines Inc.","startDate":"2017-12-13","conditions":"Hepatitis B Vaccines","enrollment":1607},{"nctId":"NCT01531075","phase":"NA","title":"Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease","status":"COMPLETED","sponsor":"Soroka University Medical Center","startDate":"2012-04","conditions":"Inflammatory Bowel Disease","enrollment":91},{"nctId":"NCT03307902","phase":"PHASE2, PHASE3","title":"ID HBV Vaccination With Imiquimod in OBI","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2016-10-01","conditions":"Hepatitis B","enrollment":120},{"nctId":"NCT01933412","phase":"PHASE3","title":"Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2012-03","conditions":"Chronic Kidney Disease, Hepatitis B","enrollment":100},{"nctId":"NCT01437475","phase":"NA","title":"Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2011-11","conditions":"HIV","enrollment":100},{"nctId":"NCT01159457","phase":"NA","title":"Comparison of Engerix B Vaccine Versus Sci-B-Vac Vaccine in Celiac Patients","status":"UNKNOWN","sponsor":"Shaare Zedek Medical Center","startDate":"2011-04","conditions":"Celiac Disease","enrollment":210},{"nctId":"NCT01133184","phase":"PHASE4","title":"Improved Prevention of Perinatal Hepatitis B Transmission","status":"UNKNOWN","sponsor":"Hadassah Medical Organization","startDate":"2010-09","conditions":"Liver Fibrosis","enrollment":6343}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Sci-B-Vac Hepatitis B Vaccine","genericName":"Sci-B-Vac Hepatitis B Vaccine","companyName":"Tel-Aviv Sourasky Medical Center","companyId":"tel-aviv-sourasky-medical-center","modality":"Biologic","firstApprovalDate":"","aiSummary":"Sci-B-Vac Hepatitis B Vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis B virus. Used for Prevention of hepatitis B infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}